TY - JOUR
T1 - Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
AU - Hedegaard, Jakob
AU - Lamy, Philippe
AU - Nordentoft, Iver
AU - Algaba, Ferran
AU - Høyer, Søren
AU - Ulhøi, Benedicte Parm
AU - Vang, Søren
AU - Reinert, Thomas
AU - Hermann, Gregers G
AU - Mogensen, Karin
AU - Thomsen, Mathilde Borg Houlberg
AU - Nielsen, Morten Muhlig
AU - Marquez, Mirari
AU - Segersten, Ulrika
AU - Aine, Mattias
AU - Höglund, Mattias
AU - Birkenkamp-Demtröder, Karin
AU - Fristrup, Niels
AU - Borre, Michael
AU - Hartmann, Arndt
AU - Stöhr, Robert
AU - Wach, Sven
AU - Keck, Bastian
AU - Seitz, Anna Katharina
AU - Nawroth, Roman
AU - Maurer, Tobias
AU - Tulic, Cane
AU - Simic, Tatjana
AU - Junker, Kerstin
AU - Horstmann, Marcus
AU - Harving, Niels
AU - Petersen, Astrid Christine
AU - Calle, M Luz
AU - Steyerberg, Ewout W
AU - Beukers, Willemien
AU - van Kessel, Kim E M
AU - Jensen, Jørgen Bjerggaard
AU - Pedersen, Jakob Skou
AU - Malmström, Per-Uno
AU - Malats, Núria
AU - Real, Francisco X
AU - Zwarthoff, Ellen C
AU - Ørntoft, Torben Falck
AU - Dyrskjøt, Lars
N1 - Copyright © 2016 Elsevier Inc. All rights reserved.
PY - 2016/7/11
Y1 - 2016/7/11
N2 - Non-muscle-invasive bladder cancer (NMIBC) is a heterogeneous disease with widely different outcomes. We performed a comprehensive transcriptional analysis of 460 early-stage urothelial carcinomas and showed that NMIBC can be subgrouped into three major classes with basal- and luminal-like characteristics and different clinical outcomes. Large differences in biological processes such as the cell cycle, epithelial-mesenchymal transition, and differentiation were observed. Analysis of transcript variants revealed frequent mutations in genes encoding proteins involved in chromatin organization and cytoskeletal functions. Furthermore, mutations in well-known cancer driver genes (e.g., TP53 and ERBB2) were primarily found in high-risk tumors, together with APOBEC-related mutational signatures. The identification of subclasses in NMIBC may offer better prognostication and treatment selection based on subclass assignment.
AB - Non-muscle-invasive bladder cancer (NMIBC) is a heterogeneous disease with widely different outcomes. We performed a comprehensive transcriptional analysis of 460 early-stage urothelial carcinomas and showed that NMIBC can be subgrouped into three major classes with basal- and luminal-like characteristics and different clinical outcomes. Large differences in biological processes such as the cell cycle, epithelial-mesenchymal transition, and differentiation were observed. Analysis of transcript variants revealed frequent mutations in genes encoding proteins involved in chromatin organization and cytoskeletal functions. Furthermore, mutations in well-known cancer driver genes (e.g., TP53 and ERBB2) were primarily found in high-risk tumors, together with APOBEC-related mutational signatures. The identification of subclasses in NMIBC may offer better prognostication and treatment selection based on subclass assignment.
UR - http://www.scopus.com/inward/record.url?scp=84979732333&partnerID=8YFLogxK
U2 - 10.1016/j.ccell.2016.05.004
DO - 10.1016/j.ccell.2016.05.004
M3 - Journal article
C2 - 27321955
SN - 1535-6108
VL - 30
SP - 27
EP - 42
JO - Cancer Cell
JF - Cancer Cell
IS - 1
ER -